Switch to Dark

Pricing

Learn

GEHC - GE Healthcare Technologies Inc

67

$71.54

-$0.66 (-0.914%)

At market close

$71.97

$0.43 (0.606%)

After Hours 3/26/26, 11:25 PM

Score

3.63/5

General

Scores

Financials & KPIs

Dividends

Analyst

Insider

GEHC

Valuation Score

View as %

Stock Unlock

YTD

Max

Stock Profile

Market Cap

$32.60B

Industry

Health Care

EPS (TTM)

$4.55

P/E (TTM)

15.64

Div & Yield

$0.14 (0.20%)

FCF Payout Ratio

4.24%

P/S (TTM)

1.58

P/B

3.14

Diluted Shares

458.00M

Ex-Dividend

2026-04-02

Next Earnings

04-27

Forward P/E

13.85

Payout Ratio

3.06%

P/FCF (TTM)

21.66

FCF Yield

4.62%

Earnings Yield

6.39%

52 Week Range

Score Card

Explore Scores Tab

3.63

Good

GE Healthcare Technologies Inc has grown revenue at 4.85% over the past year, which suggests sales are increasing. Also, it has seen its net income increase by 4.62% over the past year, which suggests its profits are growing modestly.

Valuation Model

Key Score

3.00

Average

Management

1.00

Very Bad

Growth

1.00

Very Bad

Profitability

4.00

Good

Fin. Health

2.00

Bad

Dividends

1.00

Very Bad

Analyst

1.00

Very Bad

Insider Transactions

Explore Insider Tab

Buy

Sell

Market News

Page 1 of 21

1 new filing was in the last 7 days

Filter Form Types

Form SCHEDULE 13G/A

Unknown Form Type

Filed on 2026-03-26 18:37:20

Form ARS

Unknown Form Type

Filed on 2026-03-19 07:06:02

Form DEFA14A

Additional definitive proxy soliciting materials

Filed on 2026-03-19 07:03:57

Form DEF 14A

Also known as a 'definitive proxy statement', is a required filing when a shareholder vote is required

Filed on 2026-03-19 07:02:54

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-03-17 16:08:18

Form 3

Initial statement of beneficial ownership of securities - general instructions

Filed on 2026-03-17 16:06:05

Form 8-K

Current report pursuant to Section 13 or 15(d)

Filed on 2026-03-17 09:14:16

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-03-04 16:27:18

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-03-04 16:26:57

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-03-04 16:26:16

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-03-04 16:25:51

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-03-04 16:25:24

Page 1 of 21

Financials

Explore Financials Tab

Revenue

Earnings

Free Cash Flow

Price Targets

Go to Analyst Tab

These are one year price targets for: 2027-02-21

High:

$115.50

61.4%

Avg:

$95.29

33.2%

Low:

$77.77

8.7%

(% change is relative to the current stock price: $71.54)

Analyst Recommendations

Go to Analyst Tab

3.93

Good

29%

Strong Buy (8)

39%

Buy (11)

29%

Hold (8)

Sell (1)

Strong Sell (0)

About

Website
https://www.gehealthcare.com
Address
500 West Monroe Street, Chicago ILLINOIS, US
SEC Reports
https://sec.gov/edgar/browse/?CIK=1932393

GE Healthcare Technologies, Inc. engages in the development and manufacturing of medical technology, pharmaceutical diagnostics, and digital solutions. The company is headquartered in Chicago, Illinois and currently employs 54,000 full-time employees. The company went IPO on 2022-12-15. Its business segments include Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). Its Imaging segment offers a portfolio of scanning devices, clinical applications, service capabilities, and digital solutions. Its AVS segment offers ultrasound, image guided therapies, and interventional solutions with a portfolio that spans the continuum of care, including screening, diagnosis, treatment, and monitoring of certain diseases. Its PCS segment consists of patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, maternal infant care, and consumables and services. Its PDx segment develops and produces two types of imaging agents: contrast media and radiopharmaceuticals.

IPO Date

2022-12-15

Industry

Health Care

Total Employees

54,000

Exchange

Nasdaq Nms - Global Market

Reporting Currency

USD

GICS

Health Care Equipment & Supplies

GICS Sub

Health Care Equipment

GICS Sector

Health Care

GICS Group

Health Care Equipment & Services

Switch to Dark

Pricing

Learn

GEHC - GE Healthcare Technologies Inc

67

$71.54

-$0.66 (-0.914%)

$71.97

$0.43 (0.606%)

3.63/5

Stock Unlock

Stock Profile

Score Card

Good

Insider Transactions

Market News

Form SCHEDULE 13G/A

Filed on 2026-03-26 18:37:20

Form ARS

Filed on 2026-03-19 07:06:02

Form DEFA14A

Filed on 2026-03-19 07:03:57

Form DEF 14A

Filed on 2026-03-19 07:02:54

Form 4

Filed on 2026-03-17 16:08:18

Form 3

Filed on 2026-03-17 16:06:05

Form 8-K

Filed on 2026-03-17 09:14:16

Form 4

Filed on 2026-03-04 16:27:18

Form 4

Filed on 2026-03-04 16:26:57

Form 4

Filed on 2026-03-04 16:26:16

Form 4

Filed on 2026-03-04 16:25:51

Form 4

Filed on 2026-03-04 16:25:24

Financials

Price Targets

61.4%

33.2%

8.7%

Analyst Recommendations

About

Similar Stocks